As of 12:31 PM on the 25th, Celltrion is trading at 318,500 KRW, up 2.74% from the previous day. This is a 17.06% decrease compared to January 12. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners have net sold 11,239 shares of Celltrion, while institutions have net bought 2,000 shares, according to provisional data. Over the past five days, individual investors have net bought 263,780 shares, while foreigners and institutions have net bought 17,080 shares and net sold 291,338 shares, respectively.
On January 20, Celltrion became a market topic with the headline "Rebound six trading days after the announcement of the COVID-19 treatment clinical trial."
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
